Melanoma staging explained

Your team considers the tumour’s thickness, ulceration, and whether melanoma cells are found in nearby lymph nodes. They may also use examination, imaging, or other tests when symptoms or pathology make them relevant. The result is grouped into stages that describe disease limited to the skin, disease involving regional nodes or nearby skin, or disease found in distant organs.

A stage is based on available clinical and pathology information; it can be refined after excision or node testing. It does not predict one person’s experience with certainty. The [Melanoma] overview gives broader context, while [Sentinel Lymph Node Biopsy] explains one way regional spread may be assessed.

Bring the pathology report and write down unfamiliar terms such as Breslow thickness, ulceration, margins, or sentinel node. Ask which tests are necessary for your particular findings and which are not. Treatment may include [Surgical Excision] for the primary lesion; more advanced findings can lead to discussions about [Immunotherapy] or other specialist options.

Keep copies of scan and pathology results, attend planned appointments, and check the skin and lymph-node areas your clinician identifies. Staging is a process of organising evidence, not a substitute for examining a new symptom.

Seek prompt advice for a rapidly changing or bleeding lesion, a non-healing sore, or a new firm lump near the melanoma or in a nearby lymph-node area. During treatment or staging, report persistent headaches, new weakness, breathing difficulty, unexplained pain, or marked changes in general health. These symptoms have many possible causes, but timely assessment helps your team decide whether further evaluation is needed.

Ask which stage applies now and whether it is clinical or based on surgical pathology. What do thickness, ulceration, margins, and node findings mean in my report? Do I need imaging or sentinel node sampling? How will the stage affect surgery, treatment choices, and follow-up?